Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
about
Single dose oral meloxicam for acute postoperative pain in adultsSingle dose oral etodolac for acute postoperative pain in adultsThe search for novel analgesics: targets and mechanismsA turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityA comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an exampleDesign of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretionEffect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticlesEmerging targets in lipid-based therapyComputational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Pain management in the cirrhotic patient: the clinical challenge.Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trialsThe efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens.Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current eviEffect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials.Cost-effectiveness analyses of osteoarthritis oral therapies: a systematic review.Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysisCelecoxib for osteoarthritis.Molecular docking and analgesic studies of Erythrina variegata׳s derived phytochemicals with COX enzymes.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesDiscovering the route from inflammation to pancreatic cancer.Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidanceInfluence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults.Prostacyclin: an inflammatory paradox.Brain activity for chronic knee osteoarthritis: dissociating evoked pain from spontaneous pain.A metabonomic study of adjuvant-induced arthritis in rats using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcuminSkeletal muscle protein metabolism in the elderly: Interventions to counteract the 'anabolic resistance' of ageing.Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical recordsSystematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.Cancer Pain Management and Bone Metastases: An Update for the Clinician.Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.Development and optimization of a meloxicam/β-cyclodextrin complex for orally disintegrating tablet using statistical analysis.Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.Analgesic and Toxicity Studies of Aminoacetylenic Isoindoline-1,3-dione Derivatives.Modulation of Apoptosis and Differentiation by the Treatment of Sulfasalazine in Rabbit Articular Chondrocytes.Synthesis and Biological Activity of New [1,3]Thiazolo[4,5-d]pyridazin-4(5H)-ones.Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeuticsCost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.
P2860
Q24240395-ABABE0FF-6216-481D-9C2A-7786A709F57DQ24241806-876DD1E0-960E-45D0-BA83-F5375D2C704CQ24288817-399BA1FB-8CEB-4906-AEBF-455AEF338E78Q24615651-44E4EC7E-F250-4BD7-91F7-CEFC70343AF9Q28472098-D3A5886E-C2E2-44F3-A45F-2766BC53356DQ28474126-07780B0D-93A7-4690-9A54-23339525CB85Q28542696-8975F7C8-C328-42D3-A1D7-240866552284Q28655456-106A6E67-5537-435C-B427-0D9056AFB095Q30278668-70342FF5-E8C2-4988-935B-4DC22C55158EQ30494286-D0CD32CF-1C82-4BD1-AB7D-00DC942E6725Q31142712-006B9BC4-DB3E-4D1C-A7E7-66B3785C3078Q33556721-B45F07DE-8E55-445D-B663-E49048916618Q33645667-4D4E24BA-D20C-4A67-B0CA-279768BC72FDQ33692833-97C59BAC-47EF-4E84-BD4E-76CB299B08D3Q34148370-89A29588-031B-4A5E-B79D-6048A715D9CFQ34290335-3ED76AA2-6B23-4D8A-863F-2113194879AEQ34384075-D73E7DD9-0213-4F30-8315-B4774DD21959Q34471991-08CAFCBC-BD3C-4CB7-BAF5-42746631D452Q34557021-8118989A-62D0-44E1-AAF9-13EDB054BADFQ34590606-0AD35CBA-90A1-4D27-BCA9-8559518CCF7DQ34594807-D31219C4-1D90-4B2B-A058-530496C477DEQ34645978-AF45907B-30AF-4ACA-8172-639BE136D98DQ34655792-0DED1B32-A010-4528-976F-19A331B8840CQ34720131-AA67E4C1-4CD5-4895-93F0-E2BB66361FE1Q35025863-19638B95-F6D8-47D9-882C-DF6E6DE694DBQ35041186-0D15046D-C871-4B13-A5B3-23EE48468383Q35209586-6FD46C00-B5A8-40B3-AF3E-E05E579A86C5Q35298265-837EEFC5-CB13-4854-8218-893D00453A98Q35447810-944AF1B8-61FD-4025-97A9-DB1B21F074D9Q35569771-4F33B836-7032-42AF-94A7-CB586F186F5CQ36001198-595C4349-4A79-43AC-BA6B-5DCB762E8E56Q36036131-69C223CB-6705-4CFA-B1DB-3D685038BC20Q36195392-1817A60B-61FD-4BE3-8C6D-9CA4D9B3E6D4Q36201299-77107754-9A66-4D54-8208-214C1B51FF6DQ36332697-D45EAA02-D845-4453-B70C-DD5502ACAF15Q36516027-0F8B6108-15B2-4017-A710-AB1703B6672DQ36832831-847BCC84-F833-40EA-8A37-3E7401A4F92EQ36912322-B434223E-FF7C-4BDE-875B-BAF6F0D31C25Q37056117-81BE5D9D-35C1-4287-9CBB-760817DF4269Q37272199-3707DEAF-A126-4F59-B493-CDC62C843A7C
P2860
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@ast
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@en
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@nl
type
label
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@ast
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@en
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@nl
prefLabel
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@ast
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@en
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@nl
P2093
P921
P356
P1476
Cyclooxygenase-2 selective non ...... eview and economic evaluation.
@en
P2093
Fry-Smith A
Jobanputra P
P304
1-278, iii
P356
10.3310/HTA12110
P577
2008-04-01T00:00:00Z